Global Generic Drugs Market Growth 2021-2026
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this latest study, the 2021 growth of Generic Drugs will have significant change from previous year. By the most conservative estimates of global Generic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 278980 million in 2020. Over the next five years the Generic Drugs market will register a 10.4% CAGR in terms of revenue, the global market size will reach US$ 414030 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
According to this latest study, the 2021 growth of Generic Drugs will have significant change from previous year. By the most conservative estimates of global Generic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 278980 million in 2020. Over the next five years the Generic Drugs market will register a 10.4% CAGR in terms of revenue, the global market size will reach US$ 414030 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Drugs Consumption 2016-2026
2.1.2 Generic Drugs Consumption CAGR by Region
2.2 Generic Drugs Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.3 Generic Drugs Sales by Type
2.3.1 Global Generic Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Generic Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Generic Drugs Sale Price by Type (2016-2021)
2.4 Generic Drugs Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Generic Drugs Sales by Application
2.5.1 Global Generic Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Generic Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Generic Drugs Sale Price by Application (2016-2021)
3 GLOBAL GENERIC DRUGS BY COMPANY
3.1 Global Generic Drugs Sales Market Share by Company
3.1.1 Global Generic Drugs Sales by Company (2019-2021)
3.1.2 Global Generic Drugs Sales Market Share by Company (2019-2021)
3.2 Global Generic Drugs Revenue Market Share by Company
3.2.1 Global Generic Drugs Revenue by Company (2019-2021)
3.2.2 Global Generic Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Generic Drugs Sale Price by Company
3.4 Global Manufacturers Generic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Generic Drugs Product Location Distribution
3.4.2 Players Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 GENERIC DRUGS BY REGION
4.1 Global Generic Drugs by Region
4.1.1 Global Generic Drugs Sales by Region
4.1.2 Global Generic Drugs Revenue by Region
4.2 Americas Generic Drugs Sales Growth
4.3 APAC Generic Drugs Sales Growth
4.4 Europe Generic Drugs Sales Growth
4.5 Middle East & Africa Generic Drugs Sales Growth
5 AMERICAS
5.1 Americas Generic Drugs Sales by Country
5.1.1 Americas Generic Drugs Sales by Country (2016-2021)
5.1.2 Americas Generic Drugs Revenue by Country (2016-2021)
5.2 Americas Generic Drugs Sales by Type
5.3 Americas Generic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Sales by Region
6.1.1 APAC Generic Drugs Sales by Region (2016-2021)
6.1.2 APAC Generic Drugs Revenue by Region (2016-2021)
6.2 APAC Generic Drugs Sales by Type
6.3 APAC Generic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Drugs by Country
7.1.1 Europe Generic Drugs Sales by Country (2016-2021)
7.1.2 Europe Generic Drugs Revenue by Country (2016-2021)
7.2 Europe Generic Drugs Sales by Type
7.3 Europe Generic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Drugs by Country
8.1.1 Middle East & Africa Generic Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Generic Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Generic Drugs Sales by Type
8.3 Middle East & Africa Generic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Generic Drugs Distributors
10.3 Generic Drugs Customer
11 GLOBAL GENERIC DRUGS MARKET FORECAST
11.1 Global Generic Drugs Forecast by Region
11.1.1 Global Generic Drugs Forecast by Regions (2021-2026)
11.2.2 Global Generic Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Generic Drugs Forecast by Type
11.7 Global Generic Drugs Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Generic Drugs Product Offered
12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Teva Main Business Overview
12.1.5 Teva Latest Developments
12.2 Novartis - Sandoz
12.2.1 Novartis - Sandoz Company Information
12.2.2 Novartis - Sandoz Generic Drugs Product Offered
12.2.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis - Sandoz Main Business Overview
12.2.5 Novartis - Sandoz Latest Developments
12.3 Mylan
12.3.1 Mylan Company Information
12.3.2 Mylan Generic Drugs Product Offered
12.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mylan Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Information
12.4.2 Sun Pharmaceutical Generic Drugs Product Offered
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sun Pharmaceutical Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Aspen
12.5.1 Aspen Company Information
12.5.2 Aspen Generic Drugs Product Offered
12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aspen Main Business Overview
12.5.5 Aspen Latest Developments
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Company Information
12.6.2 Fresenius Kabi Generic Drugs Product Offered
12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Fresenius Kabi Main Business Overview
12.6.5 Fresenius Kabi Latest Developments
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Company Information
12.7.2 Pfizer (Hospira) Generic Drugs Product Offered
12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Pfizer (Hospira) Main Business Overview
12.7.5 Pfizer (Hospira) Latest Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Generic Drugs Product Offered
12.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sanofi Main Business Overview
12.8.5 Sanofi Latest Developments
12.9 Aurobindo
12.9.1 Aurobindo Company Information
12.9.2 Aurobindo Generic Drugs Product Offered
12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Aurobindo Main Business Overview
12.9.5 Aurobindo Latest Developments
12.10 Lupin
12.10.1 Lupin Company Information
12.10.2 Lupin Generic Drugs Product Offered
12.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Lupin Main Business Overview
12.10.5 Lupin Latest Developments
12.11 Dr. Reddy's
12.11.1 Dr. Reddy's Company Information
12.11.2 Dr. Reddy's Generic Drugs Product Offered
12.11.3 Dr. Reddy's Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Dr. Reddy's Main Business Overview
12.11.5 Dr. Reddy's Latest Developments
12.12 Apotex
12.12.1 Apotex Company Information
12.12.2 Apotex Generic Drugs Product Offered
12.12.3 Apotex Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Apotex Main Business Overview
12.12.5 Apotex Latest Developments
12.13 Cipla
12.13.1 Cipla Company Information
12.13.2 Cipla Generic Drugs Product Offered
12.13.3 Cipla Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Cipla Main Business Overview
12.13.5 Cipla Latest Developments
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Company Information
12.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 ENDO (Par Pharmaceutical) Main Business Overview
12.14.5 ENDO (Par Pharmaceutical) Latest Developments
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Company Information
12.15.2 Stada Arzneimittel Generic Drugs Product Offered
12.15.3 Stada Arzneimittel Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Stada Arzneimittel Main Business Overview
12.15.5 Stada Arzneimittel Latest Developments
12.16 Krka Group
12.16.1 Krka Group Company Information
12.16.2 Krka Group Generic Drugs Product Offered
12.16.3 Krka Group Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Krka Group Main Business Overview
12.16.5 Krka Group Latest Developments
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Company Information
12.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Nichi-Iko Pharmaceutical Main Business Overview
12.17.5 Nichi-Iko Pharmaceutical Latest Developments
12.18 Valeant
12.18.1 Valeant Company Information
12.18.2 Valeant Generic Drugs Product Offered
12.18.3 Valeant Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Valeant Main Business Overview
12.18.5 Valeant Latest Developments
12.19 Zydus Cadila
12.19.1 Zydus Cadila Company Information
12.19.2 Zydus Cadila Generic Drugs Product Offered
12.19.3 Zydus Cadila Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Zydus Cadila Main Business Overview
12.19.5 Zydus Cadila Latest Developments
12.20 Hikma
12.20.1 Hikma Company Information
12.20.2 Hikma Generic Drugs Product Offered
12.20.3 Hikma Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Hikma Main Business Overview
12.20.5 Hikma Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Drugs Consumption 2016-2026
2.1.2 Generic Drugs Consumption CAGR by Region
2.2 Generic Drugs Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.3 Generic Drugs Sales by Type
2.3.1 Global Generic Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Generic Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Generic Drugs Sale Price by Type (2016-2021)
2.4 Generic Drugs Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Generic Drugs Sales by Application
2.5.1 Global Generic Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Generic Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Generic Drugs Sale Price by Application (2016-2021)
3 GLOBAL GENERIC DRUGS BY COMPANY
3.1 Global Generic Drugs Sales Market Share by Company
3.1.1 Global Generic Drugs Sales by Company (2019-2021)
3.1.2 Global Generic Drugs Sales Market Share by Company (2019-2021)
3.2 Global Generic Drugs Revenue Market Share by Company
3.2.1 Global Generic Drugs Revenue by Company (2019-2021)
3.2.2 Global Generic Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Generic Drugs Sale Price by Company
3.4 Global Manufacturers Generic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Generic Drugs Product Location Distribution
3.4.2 Players Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 GENERIC DRUGS BY REGION
4.1 Global Generic Drugs by Region
4.1.1 Global Generic Drugs Sales by Region
4.1.2 Global Generic Drugs Revenue by Region
4.2 Americas Generic Drugs Sales Growth
4.3 APAC Generic Drugs Sales Growth
4.4 Europe Generic Drugs Sales Growth
4.5 Middle East & Africa Generic Drugs Sales Growth
5 AMERICAS
5.1 Americas Generic Drugs Sales by Country
5.1.1 Americas Generic Drugs Sales by Country (2016-2021)
5.1.2 Americas Generic Drugs Revenue by Country (2016-2021)
5.2 Americas Generic Drugs Sales by Type
5.3 Americas Generic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Sales by Region
6.1.1 APAC Generic Drugs Sales by Region (2016-2021)
6.1.2 APAC Generic Drugs Revenue by Region (2016-2021)
6.2 APAC Generic Drugs Sales by Type
6.3 APAC Generic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Drugs by Country
7.1.1 Europe Generic Drugs Sales by Country (2016-2021)
7.1.2 Europe Generic Drugs Revenue by Country (2016-2021)
7.2 Europe Generic Drugs Sales by Type
7.3 Europe Generic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Drugs by Country
8.1.1 Middle East & Africa Generic Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Generic Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Generic Drugs Sales by Type
8.3 Middle East & Africa Generic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Generic Drugs Distributors
10.3 Generic Drugs Customer
11 GLOBAL GENERIC DRUGS MARKET FORECAST
11.1 Global Generic Drugs Forecast by Region
11.1.1 Global Generic Drugs Forecast by Regions (2021-2026)
11.2.2 Global Generic Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Generic Drugs Forecast by Type
11.7 Global Generic Drugs Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Generic Drugs Product Offered
12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Teva Main Business Overview
12.1.5 Teva Latest Developments
12.2 Novartis - Sandoz
12.2.1 Novartis - Sandoz Company Information
12.2.2 Novartis - Sandoz Generic Drugs Product Offered
12.2.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis - Sandoz Main Business Overview
12.2.5 Novartis - Sandoz Latest Developments
12.3 Mylan
12.3.1 Mylan Company Information
12.3.2 Mylan Generic Drugs Product Offered
12.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mylan Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Information
12.4.2 Sun Pharmaceutical Generic Drugs Product Offered
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sun Pharmaceutical Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Aspen
12.5.1 Aspen Company Information
12.5.2 Aspen Generic Drugs Product Offered
12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aspen Main Business Overview
12.5.5 Aspen Latest Developments
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Company Information
12.6.2 Fresenius Kabi Generic Drugs Product Offered
12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Fresenius Kabi Main Business Overview
12.6.5 Fresenius Kabi Latest Developments
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Company Information
12.7.2 Pfizer (Hospira) Generic Drugs Product Offered
12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Pfizer (Hospira) Main Business Overview
12.7.5 Pfizer (Hospira) Latest Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Generic Drugs Product Offered
12.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sanofi Main Business Overview
12.8.5 Sanofi Latest Developments
12.9 Aurobindo
12.9.1 Aurobindo Company Information
12.9.2 Aurobindo Generic Drugs Product Offered
12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Aurobindo Main Business Overview
12.9.5 Aurobindo Latest Developments
12.10 Lupin
12.10.1 Lupin Company Information
12.10.2 Lupin Generic Drugs Product Offered
12.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Lupin Main Business Overview
12.10.5 Lupin Latest Developments
12.11 Dr. Reddy's
12.11.1 Dr. Reddy's Company Information
12.11.2 Dr. Reddy's Generic Drugs Product Offered
12.11.3 Dr. Reddy's Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Dr. Reddy's Main Business Overview
12.11.5 Dr. Reddy's Latest Developments
12.12 Apotex
12.12.1 Apotex Company Information
12.12.2 Apotex Generic Drugs Product Offered
12.12.3 Apotex Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Apotex Main Business Overview
12.12.5 Apotex Latest Developments
12.13 Cipla
12.13.1 Cipla Company Information
12.13.2 Cipla Generic Drugs Product Offered
12.13.3 Cipla Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Cipla Main Business Overview
12.13.5 Cipla Latest Developments
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Company Information
12.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 ENDO (Par Pharmaceutical) Main Business Overview
12.14.5 ENDO (Par Pharmaceutical) Latest Developments
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Company Information
12.15.2 Stada Arzneimittel Generic Drugs Product Offered
12.15.3 Stada Arzneimittel Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Stada Arzneimittel Main Business Overview
12.15.5 Stada Arzneimittel Latest Developments
12.16 Krka Group
12.16.1 Krka Group Company Information
12.16.2 Krka Group Generic Drugs Product Offered
12.16.3 Krka Group Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Krka Group Main Business Overview
12.16.5 Krka Group Latest Developments
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Company Information
12.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Nichi-Iko Pharmaceutical Main Business Overview
12.17.5 Nichi-Iko Pharmaceutical Latest Developments
12.18 Valeant
12.18.1 Valeant Company Information
12.18.2 Valeant Generic Drugs Product Offered
12.18.3 Valeant Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Valeant Main Business Overview
12.18.5 Valeant Latest Developments
12.19 Zydus Cadila
12.19.1 Zydus Cadila Company Information
12.19.2 Zydus Cadila Generic Drugs Product Offered
12.19.3 Zydus Cadila Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Zydus Cadila Main Business Overview
12.19.5 Zydus Cadila Latest Developments
12.20 Hikma
12.20.1 Hikma Company Information
12.20.2 Hikma Generic Drugs Product Offered
12.20.3 Hikma Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Hikma Main Business Overview
12.20.5 Hikma Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Generic Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Simple Generic Drugs
Table 3. Major Players of Super Generic Drugs
Table 4. Major Players of Biosimilars
Table 5. Global Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 6. Global Generic Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Generic Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Generic Drugs Sale Price by Type (2016-2021)
Table 10. Global Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 11. Global Generic Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Generic Drugs Value by Application (2016-2021)
Table 13. Global Generic Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Generic Drugs Sale Price by Application (2016-2021)
Table 15. Global Generic Drugs Sales by Company (2019-2021) & (K MT)
Table 16. Global Generic Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Generic Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Generic Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Generic Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Generic Drugs Producing Area Distribution and Sales Area
Table 21. Players Generic Drugs Products Offered
Table 22. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Generic Drugs Sales by Region (2016-2021) (K MT)
Table 26. Global Generic Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Generic Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Generic Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 30. Americas Generic Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Generic Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 34. Americas Generic Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 36. Americas Generic Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Generic Drugs Sales by Region (2016-2021) & (K MT)
Table 38. APAC Generic Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Generic Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Generic Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 42. APAC Generic Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 44. APAC Generic Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 46. Europe Generic Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Generic Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 50. Europe Generic Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 52. Europe Generic Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Generic Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Generic Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Generic Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Generic Drugs Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Generic Drugs
Table 62. Key Application and Potential Industries of Generic Drugs
Table 63. Key Challenges of Generic Drugs
Table 64. Key Trends of Generic Drugs
Table 65. Generic Drugs Distributors List
Table 66. Generic Drugs Customer List
Table 67. Global Generic Drugs Sales Forecast by Region (2021-2026) & (K MT)
Table 68. Global Generic Drugs Consumption Market Forecast by Region
Table 69. Global Generic Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Generic Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 72. Americas Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Generic Drugs Sales Forecast by Region (2021-2026) & (K MT)
Table 74. APAC Generic Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 76. Europe Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 78. Middle East & Africa Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Generic Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 80. Global Generic Drugs Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Generic Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Generic Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Generic Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 84. Global Generic Drugs Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Generic Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Generic Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 87. Teva Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Generic Drugs Product Offered
Table 89. Teva Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 90. Teva Main Business
Table 91. Teva Latest Developments
Table 92. Novartis - Sandoz Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis - Sandoz Generic Drugs Product Offered
Table 94. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 95. Novartis - Sandoz Main Business
Table 96. Novartis - Sandoz Latest Developments
Table 97. Mylan Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Generic Drugs Product Offered
Table 99. Mylan Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Sun Pharmaceutical Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Generic Drugs Product Offered
Table 104. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 105. Sun Pharmaceutical Main Business
Table 106. Sun Pharmaceutical Latest Developments
Table 107. Aspen Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Aspen Generic Drugs Product Offered
Table 109. Aspen Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 110. Aspen Main Business
Table 111. Aspen Latest Developments
Table 112. Fresenius Kabi Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Fresenius Kabi Generic Drugs Product Offered
Table 114. Fresenius Kabi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 115. Fresenius Kabi Main Business
Table 116. Fresenius Kabi Latest Developments
Table 117. Pfizer (Hospira) Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer (Hospira) Generic Drugs Product Offered
Table 119. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 120. Pfizer (Hospira) Main Business
Table 121. Pfizer (Hospira) Latest Developments
Table 122. Sanofi Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Generic Drugs Product Offered
Table 124. Sanofi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments
Table 127. Aurobindo Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Aurobindo Generic Drugs Product Offered
Table 129. Aurobindo Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 130. Aurobindo Main Business
Table 131. Aurobindo Latest Developments
Table 132. Lupin Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Lupin Generic Drugs Product Offered
Table 134. Lupin Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 135. Lupin Main Business
Table 136. Lupin Latest Developments
Table 137. Dr. Reddy's Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Dr. Reddy's Generic Drugs Product Offered
Table 139. Dr. Reddy's Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 140. Dr. Reddy's Main Business
Table 141. Dr. Reddy's Latest Developments
Table 142. Apotex Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Apotex Generic Drugs Product Offered
Table 144. Apotex Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 145. Apotex Main Business
Table 146. Apotex Latest Developments
Table 147. Cipla Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Cipla Generic Drugs Product Offered
Table 149. Cipla Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 150. Cipla Main Business
Table 151. Cipla Latest Developments
Table 152. ENDO (Par Pharmaceutical) Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. ENDO (Par Pharmaceutical) Generic Drugs Product Offered
Table 154. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 155. ENDO (Par Pharmaceutical) Main Business
Table 156. ENDO (Par Pharmaceutical) Latest Developments
Table 157. Stada Arzneimittel Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Stada Arzneimittel Generic Drugs Product Offered
Table 159. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 160. Stada Arzneimittel Main Business
Table 161. Stada Arzneimittel Latest Developments
Table 162. Krka Group Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Krka Group Generic Drugs Product Offered
Table 164. Krka Group Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 165. Krka Group Main Business
Table 166. Krka Group Latest Developments
Table 167. Nichi-Iko Pharmaceutical Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Nichi-Iko Pharmaceutical Generic Drugs Product Offered
Table 169. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 170. Nichi-Iko Pharmaceutical Main Business
Table 171. Nichi-Iko Pharmaceutical Latest Developments
Table 172. Valeant Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Valeant Generic Drugs Product Offered
Table 174. Valeant Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 175. Valeant Main Business
Table 176. Valeant Latest Developments
Table 177. Zydus Cadila Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Zydus Cadila Generic Drugs Product Offered
Table 179. Zydus Cadila Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 180. Zydus Cadila Main Business
Table 181. Zydus Cadila Latest Developments
Table 182. Hikma Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Hikma Generic Drugs Product Offered
Table 184. Hikma Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 185. Hikma Main Business
Table 186. Hikma Latest Developments
Table 1. Generic Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Simple Generic Drugs
Table 3. Major Players of Super Generic Drugs
Table 4. Major Players of Biosimilars
Table 5. Global Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 6. Global Generic Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Generic Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Generic Drugs Sale Price by Type (2016-2021)
Table 10. Global Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 11. Global Generic Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Generic Drugs Value by Application (2016-2021)
Table 13. Global Generic Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Generic Drugs Sale Price by Application (2016-2021)
Table 15. Global Generic Drugs Sales by Company (2019-2021) & (K MT)
Table 16. Global Generic Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Generic Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Generic Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Generic Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Generic Drugs Producing Area Distribution and Sales Area
Table 21. Players Generic Drugs Products Offered
Table 22. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Generic Drugs Sales by Region (2016-2021) (K MT)
Table 26. Global Generic Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Generic Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Generic Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 30. Americas Generic Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Generic Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 34. Americas Generic Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 36. Americas Generic Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Generic Drugs Sales by Region (2016-2021) & (K MT)
Table 38. APAC Generic Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Generic Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Generic Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 42. APAC Generic Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 44. APAC Generic Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 46. Europe Generic Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Generic Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 50. Europe Generic Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 52. Europe Generic Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Generic Drugs Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Generic Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Generic Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Generic Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Generic Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Generic Drugs Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Generic Drugs
Table 62. Key Application and Potential Industries of Generic Drugs
Table 63. Key Challenges of Generic Drugs
Table 64. Key Trends of Generic Drugs
Table 65. Generic Drugs Distributors List
Table 66. Generic Drugs Customer List
Table 67. Global Generic Drugs Sales Forecast by Region (2021-2026) & (K MT)
Table 68. Global Generic Drugs Consumption Market Forecast by Region
Table 69. Global Generic Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Generic Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 72. Americas Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Generic Drugs Sales Forecast by Region (2021-2026) & (K MT)
Table 74. APAC Generic Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 76. Europe Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Generic Drugs Sales Forecast by Country (2021-2026) & (K MT)
Table 78. Middle East & Africa Generic Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Generic Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 80. Global Generic Drugs Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Generic Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Generic Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Generic Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 84. Global Generic Drugs Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Generic Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Generic Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 87. Teva Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Generic Drugs Product Offered
Table 89. Teva Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 90. Teva Main Business
Table 91. Teva Latest Developments
Table 92. Novartis - Sandoz Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis - Sandoz Generic Drugs Product Offered
Table 94. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 95. Novartis - Sandoz Main Business
Table 96. Novartis - Sandoz Latest Developments
Table 97. Mylan Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Generic Drugs Product Offered
Table 99. Mylan Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Sun Pharmaceutical Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Generic Drugs Product Offered
Table 104. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 105. Sun Pharmaceutical Main Business
Table 106. Sun Pharmaceutical Latest Developments
Table 107. Aspen Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Aspen Generic Drugs Product Offered
Table 109. Aspen Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 110. Aspen Main Business
Table 111. Aspen Latest Developments
Table 112. Fresenius Kabi Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Fresenius Kabi Generic Drugs Product Offered
Table 114. Fresenius Kabi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 115. Fresenius Kabi Main Business
Table 116. Fresenius Kabi Latest Developments
Table 117. Pfizer (Hospira) Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer (Hospira) Generic Drugs Product Offered
Table 119. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 120. Pfizer (Hospira) Main Business
Table 121. Pfizer (Hospira) Latest Developments
Table 122. Sanofi Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Generic Drugs Product Offered
Table 124. Sanofi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments
Table 127. Aurobindo Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Aurobindo Generic Drugs Product Offered
Table 129. Aurobindo Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 130. Aurobindo Main Business
Table 131. Aurobindo Latest Developments
Table 132. Lupin Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Lupin Generic Drugs Product Offered
Table 134. Lupin Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 135. Lupin Main Business
Table 136. Lupin Latest Developments
Table 137. Dr. Reddy's Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Dr. Reddy's Generic Drugs Product Offered
Table 139. Dr. Reddy's Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 140. Dr. Reddy's Main Business
Table 141. Dr. Reddy's Latest Developments
Table 142. Apotex Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Apotex Generic Drugs Product Offered
Table 144. Apotex Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 145. Apotex Main Business
Table 146. Apotex Latest Developments
Table 147. Cipla Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Cipla Generic Drugs Product Offered
Table 149. Cipla Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 150. Cipla Main Business
Table 151. Cipla Latest Developments
Table 152. ENDO (Par Pharmaceutical) Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. ENDO (Par Pharmaceutical) Generic Drugs Product Offered
Table 154. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 155. ENDO (Par Pharmaceutical) Main Business
Table 156. ENDO (Par Pharmaceutical) Latest Developments
Table 157. Stada Arzneimittel Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Stada Arzneimittel Generic Drugs Product Offered
Table 159. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 160. Stada Arzneimittel Main Business
Table 161. Stada Arzneimittel Latest Developments
Table 162. Krka Group Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Krka Group Generic Drugs Product Offered
Table 164. Krka Group Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 165. Krka Group Main Business
Table 166. Krka Group Latest Developments
Table 167. Nichi-Iko Pharmaceutical Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Nichi-Iko Pharmaceutical Generic Drugs Product Offered
Table 169. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 170. Nichi-Iko Pharmaceutical Main Business
Table 171. Nichi-Iko Pharmaceutical Latest Developments
Table 172. Valeant Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Valeant Generic Drugs Product Offered
Table 174. Valeant Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 175. Valeant Main Business
Table 176. Valeant Latest Developments
Table 177. Zydus Cadila Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Zydus Cadila Generic Drugs Product Offered
Table 179. Zydus Cadila Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 180. Zydus Cadila Main Business
Table 181. Zydus Cadila Latest Developments
Table 182. Hikma Basic Information, Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Hikma Generic Drugs Product Offered
Table 184. Hikma Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 185. Hikma Main Business
Table 186. Hikma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Generic Drugs
Figure 2. Generic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Generic Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Generic Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Generic Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Simple Generic Drugs
Figure 10. Product Picture of Super Generic Drugs
Figure 11. Product Picture of Biosimilars
Figure 12. Global Generic Drugs Sales Market Share by Type in 2020
Figure 13. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Generic Drugs Consumed in CNS
Figure 15. Global Generic Drugs Market: CNS (2016-2021) & (K MT)
Figure 16. Generic Drugs Consumed in Cardiovascular
Figure 17. Global Generic Drugs Market: Cardiovascular (2016-2021) & (K MT)
Figure 18. Generic Drugs Consumed in Genitourinary/Hormonal Drugs
Figure 19. Global Generic Drugs Market: Genitourinary/Hormonal Drugs (2016-2021) & (K MT)
Figure 20. Generic Drugs Consumed in Respiratory
Figure 21. Global Generic Drugs Market: Respiratory (2016-2021) & (K MT)
Figure 22. Generic Drugs Consumed in Rheumatology
Figure 23. Global Generic Drugs Market: Rheumatology (2016-2021) & (K MT)
Figure 24. Generic Drugs Consumed in Diabetes
Figure 25. Global Generic Drugs Market: Diabetes (2016-2021) & (K MT)
Figure 26. Generic Drugs Consumed in Oncology
Figure 27. Global Generic Drugs Market: Oncology (2016-2021) & (K MT)
Figure 28. Generic Drugs Consumed in Others
Figure 29. Global Generic Drugs Market: Others (2016-2021) & (K MT)
Figure 30. Global Generic Drugs Sales Market Share by Application (2016-2021)
Figure 31. Global Generic Drugs Revenue Market Share by Application in 2020
Figure 32. Generic Drugs Revenue Market by Company in 2020 ($ Million)
Figure 33. Global Generic Drugs Revenue Market Share by Company in 2020
Figure 34. Global Generic Drugs Sales Market Share by Regions (2016-2021)
Figure 35. Global Generic Drugs Revenue Market Share by Region in 2020
Figure 36. Americas Generic Drugs Sales 2016-2021 (K MT)
Figure 37. Americas Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 38. APAC Generic Drugs Sales 2016-2021 (K MT)
Figure 39. APAC Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Europe Generic Drugs Sales 2016-2021 (K MT)
Figure 41. Europe Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 42. Middle East & Africa Generic Drugs Sales 2016-2021 (K MT)
Figure 43. Middle East & Africa Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 44. Americas Generic Drugs Sales Market Share by Country in 2020
Figure 45. Americas Generic Drugs Revenue Market Share by Country in 2020
Figure 46. Americas Generic Drugs Sales Market Share by Type in 2020
Figure 47. Americas Generic Drugs Sales Market Share by Application in 2020
Figure 48. United States Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Canada Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Mexico Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Brazil Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. APAC Generic Drugs Sales Market Share by Region in 2020
Figure 53. APAC Generic Drugs Revenue Market Share by Regions in 2020
Figure 54. APAC Generic Drugs Sales Market Share by Type in 2020
Figure 55. APAC Generic Drugs Sales Market Share by Application in 2020
Figure 56. China Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Japan Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Korea Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Southeast Asia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. India Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Australia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Europe Generic Drugs Sales Market Share by Country in 2020
Figure 63. Europe Generic Drugs Revenue Market Share by Country in 2020
Figure 64. Europe Generic Drugs Sales Market Share by Type in 2020
Figure 65. Europe Generic Drugs Sales Market Share by Application in 2020
Figure 66. Germany Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. France Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. UK Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Italy Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Russia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Middle East & Africa Generic Drugs Sales Market Share by Country in 2020
Figure 72. Middle East & Africa Generic Drugs Revenue Market Share by Country in 2020
Figure 73. Middle East & Africa Generic Drugs Sales Market Share by Type in 2020
Figure 74. Middle East & Africa Generic Drugs Sales Market Share by Application in 2020
Figure 75. Egypt Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. South Africa Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 77. Israel Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 78. Turkey Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 79. GCC Country Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 1. Picture of Generic Drugs
Figure 2. Generic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Generic Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Generic Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Generic Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Simple Generic Drugs
Figure 10. Product Picture of Super Generic Drugs
Figure 11. Product Picture of Biosimilars
Figure 12. Global Generic Drugs Sales Market Share by Type in 2020
Figure 13. Global Generic Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Generic Drugs Consumed in CNS
Figure 15. Global Generic Drugs Market: CNS (2016-2021) & (K MT)
Figure 16. Generic Drugs Consumed in Cardiovascular
Figure 17. Global Generic Drugs Market: Cardiovascular (2016-2021) & (K MT)
Figure 18. Generic Drugs Consumed in Genitourinary/Hormonal Drugs
Figure 19. Global Generic Drugs Market: Genitourinary/Hormonal Drugs (2016-2021) & (K MT)
Figure 20. Generic Drugs Consumed in Respiratory
Figure 21. Global Generic Drugs Market: Respiratory (2016-2021) & (K MT)
Figure 22. Generic Drugs Consumed in Rheumatology
Figure 23. Global Generic Drugs Market: Rheumatology (2016-2021) & (K MT)
Figure 24. Generic Drugs Consumed in Diabetes
Figure 25. Global Generic Drugs Market: Diabetes (2016-2021) & (K MT)
Figure 26. Generic Drugs Consumed in Oncology
Figure 27. Global Generic Drugs Market: Oncology (2016-2021) & (K MT)
Figure 28. Generic Drugs Consumed in Others
Figure 29. Global Generic Drugs Market: Others (2016-2021) & (K MT)
Figure 30. Global Generic Drugs Sales Market Share by Application (2016-2021)
Figure 31. Global Generic Drugs Revenue Market Share by Application in 2020
Figure 32. Generic Drugs Revenue Market by Company in 2020 ($ Million)
Figure 33. Global Generic Drugs Revenue Market Share by Company in 2020
Figure 34. Global Generic Drugs Sales Market Share by Regions (2016-2021)
Figure 35. Global Generic Drugs Revenue Market Share by Region in 2020
Figure 36. Americas Generic Drugs Sales 2016-2021 (K MT)
Figure 37. Americas Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 38. APAC Generic Drugs Sales 2016-2021 (K MT)
Figure 39. APAC Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Europe Generic Drugs Sales 2016-2021 (K MT)
Figure 41. Europe Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 42. Middle East & Africa Generic Drugs Sales 2016-2021 (K MT)
Figure 43. Middle East & Africa Generic Drugs Revenue 2016-2021 ($ Millions)
Figure 44. Americas Generic Drugs Sales Market Share by Country in 2020
Figure 45. Americas Generic Drugs Revenue Market Share by Country in 2020
Figure 46. Americas Generic Drugs Sales Market Share by Type in 2020
Figure 47. Americas Generic Drugs Sales Market Share by Application in 2020
Figure 48. United States Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Canada Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Mexico Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Brazil Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. APAC Generic Drugs Sales Market Share by Region in 2020
Figure 53. APAC Generic Drugs Revenue Market Share by Regions in 2020
Figure 54. APAC Generic Drugs Sales Market Share by Type in 2020
Figure 55. APAC Generic Drugs Sales Market Share by Application in 2020
Figure 56. China Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Japan Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Korea Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Southeast Asia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. India Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Australia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Europe Generic Drugs Sales Market Share by Country in 2020
Figure 63. Europe Generic Drugs Revenue Market Share by Country in 2020
Figure 64. Europe Generic Drugs Sales Market Share by Type in 2020
Figure 65. Europe Generic Drugs Sales Market Share by Application in 2020
Figure 66. Germany Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. France Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. UK Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Italy Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Russia Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Middle East & Africa Generic Drugs Sales Market Share by Country in 2020
Figure 72. Middle East & Africa Generic Drugs Revenue Market Share by Country in 2020
Figure 73. Middle East & Africa Generic Drugs Sales Market Share by Type in 2020
Figure 74. Middle East & Africa Generic Drugs Sales Market Share by Application in 2020
Figure 75. Egypt Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. South Africa Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 77. Israel Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 78. Turkey Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 79. GCC Country Generic Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
